Diabetes Technology: State of the Art

被引:4
作者
Heinemann, Lutz [1 ,2 ,3 ,4 ]
机构
[1] Univ Dusseldorf, Physiol Inst, Dusseldorf, Germany
[2] Univ Dusseldorf, Klin Ernahrung & Stoffwechsel, Dusseldorf, Germany
[3] Stoffwechselforsch GmbH, Profil Inst, Neuss, Germany
[4] Sci Consulting Diabet GmbH, Dusseldorf, Germany
关键词
EUROPEAN ASSOCIATION; INSULIN INJECTIONS; JOINT STATEMENT; WORKING GROUP; TYPE-1; ADULTS; TRIAL; MULTICENTER; PATIENT; SAFETY;
D O I
10.1055/s-0043-124750
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the last decades diabetes technology has developed into an integer part of diabetes therapy. A number of different technologies, most of them are also related to digitalization, are summarized under this heading: Techniques that enable a more accurate and reliable diagnostic approach, i.âŠe. glucose measurement for both, follow-up and diabetes diagnosis. Self-monitoring of capillary blood glucose samples is still a cornerstone of diabetes therapy of most patients with diabetes. It is impressive to see which level of measurement accuracy is possible with modern devices. With a smarter handling of the glucose information collected, i.âŠe. better translation into therapeutic action, improvements in patientÊs overall glucose control and well-being can be achieved. Technological advancements also helped to improve insulin pens and insulin pumps in the last years considerably, especially the development of thin and short needles. Bringing the glucose information with the therapeutic options available in a smart way enables construction of systems that automatically adjust insulin dosing to the individual needs and situation. Artificial pancreas systems will be used most probably by a considerable part of patients with diabetes, depending mainly on the costs involved. Digitalization will massively change the way patients are treated in the future, many decisions will not be made by the diabetologist and his team, but by smart algorithms. Such developments are associated with a number of aspects like data privacy that require careful handling and attention by diabetes medical associations. In summary, diabetes technology represents already an important pillar of diabetes therapy that most probably will gain an even bigger role in the future. ©Georg Thieme Verlag KG, Stuttgart New York.
引用
收藏
页码:329 / 342
页数:14
相关论文
共 23 条
  • [1] Psychosocial aspects of closed-and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting
    Barnard, K. D.
    Wysocki, T.
    Thabit, H.
    Evans, M. L.
    Amiel, S.
    Heller, S.
    Young, A.
    Hovorka, R.
    [J]. DIABETIC MEDICINE, 2015, 32 (05) : 601 - 608
  • [2] Barnard Katharine D, 2015, J Diabetes Sci Technol, V9, P925, DOI 10.1177/1932296815588332
  • [3] Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial
    Beck, Roy W.
    Riddlesworth, Tonya
    Ruedy, Katrina
    Ahmann, Andrew
    Bergenstal, Richard
    Haller, Stacie
    Kollman, Craig
    Kruger, Davida
    McGill, Janet B.
    Polonsky, William
    Toschi, Elena
    Wolpert, Howard
    Price, David
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04): : 371 - 378
  • [4] Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
    Bergenstal, Richard M.
    Garg, Satish
    Weinzimer, Stuart A.
    Buckingham, Bruce A.
    Bode, Bruce W.
    Tamborlane, William V.
    Kaufman, Francine R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (13): : 1407 - 1408
  • [5] Gehr Bernhard, 2017, J Diabetes Sci Technol, V11, P284, DOI 10.1177/1932296816661735
  • [6] Heinemann L, 2016, DIABETOLOGE, V12, P533, DOI 10.1007/s11428-016-0155-9
  • [7] Heinemann L, 2017, IDF K 2017 AB DHAB
  • [8] Heinemann L, 2018, STOFFWECHSEL HERZ, V27, P117
  • [9] Heinemann L, 2017, DTSCH ARZTEBL, V114, P26
  • [10] Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
    Heinemann, Lutz
    Freckmann, Guido
    Ehrmann, Dominic
    Faber-Heinemann, Gabriele
    Guerra, Stefania
    Waldenmaier, Delia
    Hermanns, Norbert
    [J]. LANCET, 2018, 391 (10128) : 1367 - 1377